About IHL Shinagawa East One Medical Clinic
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at IHL Shinagawa East One Medical Clinic
During the past decade, IHL Shinagawa East One Medical Clinic conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on
average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Linagliptin as Add on Therapy to Empagliflozin 10 mg or 25 mg With Japanese Patients With Type 2 Diabetes Mellitus
2015-05-12
2017-06-16
Completed
880
A Study of Tirzepatide (LY3298176) Compared to Dulaglutide in Participants With Type 2 Diabetes
2019-05-07
2021-03-31
Completed
636
A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Not Controlled With Diet and Exercise Alone
2019-06-03
2020-10-28
Completed
478
A Study to Test How Well Empagliflozin Works in Japanese People With Type 2 Diabetes Who Are Older Than 65 Years
2020-10-05
2022-08-26
Completed
129
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "IHL Shinagawa East One Medical Clinic"
#1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at IHL Shinagawa East One Medical Clinic
According to Clinical.Site data, the most researched conditions in "IHL Shinagawa East One Medical Clinic" are
"Diabetes Mellitus, Type 2" (2 trials), "Type 2 Diabetes" (1 trials) and "Type 2 Diabetes Mellitus" (1 trials). Many other conditions were trialed in "IHL Shinagawa East One Medical Clinic" in a lesser frequency.
Clinical Trials Intervention Types at IHL Shinagawa East One Medical Clinic
Most popular intervention types in "IHL Shinagawa East One Medical Clinic" are "Drug" (4 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "Tirzepatide" (2 trials), "Dulaglutide" (1 trials), "Empagliflozin" (1 trials) and "empagliflozin 10 mg" (1 trials). Other intervention names were less common.
Clinical Trials Genders at IHL Shinagawa East One Medical Clinic
The vast majority of trials in "IHL Shinagawa East One Medical Clinic" are
4 trials for "All" genders.
Clinical Trials Status at IHL Shinagawa East One Medical Clinic
Currently, there are NaN active trials in "IHL Shinagawa East One Medical Clinic".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in IHL Shinagawa East One Medical Clinic,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in IHL Shinagawa East One Medical Clinic, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".